Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data

Here are a few of the highlights from the conference:Companies are also pivoting away from focusing on weight loss alone in trials. Some drugmakers are examining their drugs' potential to treat other health conditions, while others are seeing whether a medication can preserve lean muscle mass in patients while also promoting weight loss.But drugmakers presented treatments that use different approaches than traditional GLP-1s such as Novo Nordisk's popular weight loss injection Wegovy and diabetes counterpar ...